The company said revenue for Q2 2025 was $111.6 billion, diluted earnings per share were $3.74, and adjusted earnings per share were $4.08. Revenue for Q2 rose $12.8 billion from $98.9 billion a year earlier.

1. 01

   The company said revenue for Q2 2025 was $111.6 billion, diluted earnings per share were $3.74, and adjusted earnings per share were $4.08. Revenue for Q2 rose $12.8 billion from $98.9 billion a year earlier.

2. 02

   UnitedHealth Group said earnings from operations for Q2 2025 were $5.2 billion, and net margin was 3.1%. The company said the results for Q2 reflected $1.2 billion of unfavorable discrete impacts, including $620 million related to the individual exchange business.

3. 03

   The company said its consolidated medical care ratio for Q2 2025 was 89.4%, up 430 basis points year over year. It cited medical cost trends that significantly exceeded pricing trends and the ongoing effects of Medicare funding reductions as factors.

4. 04

   On May 13, the company re-established its 2025 outlook, which it had suspended, and projected revenue of $445.5 billion to $448.0 billion, net earnings of at least $14.65 per share, and adjusted earnings of at least $16.00 per share. The company said the new outlook reflects first-half performance and its expectations for the rest of the year, including higher realized and anticipated care trends.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.